As the global economy mends, the 2021 growth of Parkinson's Disease Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Parkinson's Disease Therapeutics market size is USD million in 2022 from USD 2362.5 million in 2021, with a change of % between 2021 and 2022. The global Parkinson's Disease Therapeutics market size will reach USD 3605.2 million in 2028, growing at a CAGR of 6.2% over the analysis period.
The United States Parkinson's Disease Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Parkinson's Disease Therapeutics market, reaching US$ million by the year 2028. As for the Europe Parkinson's Disease Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Parkinson's Disease Therapeutics players cover Merck, Akorn, GSK, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson's Disease Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Sinemet-CR
- Trastal
- Madopar
- COMT Inhibitor
- Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Roche
- H.Lundbeck
- Bausch Health
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Desitin Arzneimittel
- Endo Pharmaceuticals
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size 2017-2028
2.1.2 Parkinson's Disease Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Parkinson's Disease Therapeutics Segment by Type
2.2.1 Sinemet-CR
2.2.2 Trastal
2.2.3 Madopar
2.2.4 COMT Inhibitor
2.2.5 Other
2.3 Parkinson's Disease Therapeutics Market Size by Type
2.3.1 Parkinson's Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Parkinson's Disease Therapeutics Segment by Application
2.4.1 Under 40 Years Old
2.4.2 40-65 Years Old
2.4.3 Above 65 Years Old
2.5 Parkinson's Disease Therapeutics Market Size by Application
2.5.1 Parkinson's Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Parkinson's Disease Therapeutics Market Size Market Share by Application (2017-2022)
3 Parkinson's Disease Therapeutics Market Size by Player
3.1 Parkinson's Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Parkinson's Disease Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Parkinson's Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Parkinson's Disease Therapeutics by Regions
4.1 Parkinson's Disease Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Parkinson's Disease Therapeutics Market Size Growth (2017-2022)
4.3 APAC Parkinson's Disease Therapeutics Market Size Growth (2017-2022)
4.4 Europe Parkinson's Disease Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Parkinson's Disease Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Parkinson's Disease Therapeutics Market Size by Country (2017-2022)
5.2 Americas Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
5.3 Americas Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson's Disease Therapeutics Market Size by Region (2017-2022)
6.2 APAC Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
6.3 APAC Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Parkinson's Disease Therapeutics by Country (2017-2022)
7.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Parkinson's Disease Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Parkinson's Disease Therapeutics Market Forecast
10.1 Global Parkinson's Disease Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Parkinson's Disease Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Parkinson's Disease Therapeutics Forecast
10.1.3 APAC Parkinson's Disease Therapeutics Forecast
10.1.4 Europe Parkinson's Disease Therapeutics Forecast
10.1.5 Middle East & Africa Parkinson's Disease Therapeutics Forecast
10.2 Americas Parkinson's Disease Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Parkinson's Disease Therapeutics Market Forecast
10.2.2 Canada Parkinson's Disease Therapeutics Market Forecast
10.2.3 Mexico Parkinson's Disease Therapeutics Market Forecast
10.2.4 Brazil Parkinson's Disease Therapeutics Market Forecast
10.3 APAC Parkinson's Disease Therapeutics Forecast by Region (2023-2028)
10.3.1 China Parkinson's Disease Therapeutics Market Forecast
10.3.2 Japan Parkinson's Disease Therapeutics Market Forecast
10.3.3 Korea Parkinson's Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Parkinson's Disease Therapeutics Market Forecast
10.3.5 India Parkinson's Disease Therapeutics Market Forecast
10.3.6 Australia Parkinson's Disease Therapeutics Market Forecast
10.4 Europe Parkinson's Disease Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Parkinson's Disease Therapeutics Market Forecast
10.4.2 France Parkinson's Disease Therapeutics Market Forecast
10.4.3 UK Parkinson's Disease Therapeutics Market Forecast
10.4.4 Italy Parkinson's Disease Therapeutics Market Forecast
10.4.5 Russia Parkinson's Disease Therapeutics Market Forecast
10.5 Middle East & Africa Parkinson's Disease Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Parkinson's Disease Therapeutics Market Forecast
10.5.2 South Africa Parkinson's Disease Therapeutics Market Forecast
10.5.3 Israel Parkinson's Disease Therapeutics Market Forecast
10.5.4 Turkey Parkinson's Disease Therapeutics Market Forecast
10.5.5 GCC Countries Parkinson's Disease Therapeutics Market Forecast
10.6 Global Parkinson's Disease Therapeutics Forecast by Type (2023-2028)
10.7 Global Parkinson's Disease Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Parkinson's Disease Therapeutics Product Offered
11.1.3 Merck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Akorn
11.2.1 Akorn Company Information
11.2.2 Akorn Parkinson's Disease Therapeutics Product Offered
11.2.3 Akorn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Akorn Main Business Overview
11.2.5 Akorn Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Parkinson's Disease Therapeutics Product Offered
11.3.3 GSK Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Parkinson's Disease Therapeutics Product Offered
11.4.3 Novartis Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Offered
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Information
11.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Offered
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Teva Pharmaceutical Main Business Overview
11.6.5 Teva Pharmaceutical Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Parkinson's Disease Therapeutics Product Offered
11.7.3 Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Information
11.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Offered
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview
11.8.5 Kyowa Hakko Kirin Pharma Latest Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Information
11.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Offered
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Astellas Pharma Main Business Overview
11.9.5 Astellas Pharma Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Parkinson's Disease Therapeutics Product Offered
11.10.3 Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11. H.Lundbeck
11.11.1 H.Lundbeck Company Information
11.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Offered
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 H.Lundbeck Main Business Overview
11.11.5 H.Lundbeck Latest Developments
11.12 Bausch Health
11.12.1 Bausch Health Company Information
11.12.2 Bausch Health Parkinson's Disease Therapeutics Product Offered
11.12.3 Bausch Health Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bausch Health Main Business Overview
11.12.5 Bausch Health Latest Developments
11.13 Apokyn
11.13.1 Apokyn Company Information
11.13.2 Apokyn Parkinson's Disease Therapeutics Product Offered
11.13.3 Apokyn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Apokyn Main Business Overview
11.13.5 Apokyn Latest Developments
11.14 Orion
11.14.1 Orion Company Information
11.14.2 Orion Parkinson's Disease Therapeutics Product Offered
11.14.3 Orion Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Orion Main Business Overview
11.14.5 Orion Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Offered
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 US WorldMeds
11.16.1 US WorldMeds Company Information
11.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Offered
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 US WorldMeds Main Business Overview
11.16.5 US WorldMeds Latest Developments
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Information
11.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Offered
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Desitin Arzneimittel Main Business Overview
11.17.5 Desitin Arzneimittel Latest Developments
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Information
11.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Offered
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Endo Pharmaceuticals Main Business Overview
11.18.5 Endo Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Parkinson's Disease Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Sinemet-CR
Table 3. Major Players of Trastal
Table 4. Major Players of Madopar
Table 5. Major Players of COMT Inhibitor
Table 6. Major Players of Other
Table 7. Parkinson's Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 10. Parkinson's Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Parkinson's Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 13. Global Parkinson's Disease Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Parkinson's Disease Therapeutics Revenue Market Share by Player (2020-2022)
Table 15. Parkinson's Disease Therapeutics Key Players Head office and Products Offered
Table 16. Parkinson's Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Parkinson's Disease Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Parkinson's Disease Therapeutics Market Size Market Share by Regions (2017-2022)
Table 21. Americas Parkinson's Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Parkinson's Disease Therapeutics Market Size Market Share by Country (2017-2022)
Table 23. Americas Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Parkinson's Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 25. Americas Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Parkinson's Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 27. APAC Parkinson's Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Parkinson's Disease Therapeutics Market Size Market Share by Region (2017-2022)
Table 29. APAC Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Parkinson's Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 31. APAC Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Parkinson's Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 33. Europe Parkinson's Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Parkinson's Disease Therapeutics Market Size Market Share by Country (2017-2022)
Table 35. Europe Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Parkinson's Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 37. Europe Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Parkinson's Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Parkinson's Disease Therapeutics Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Parkinson's Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Parkinson's Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Parkinson's Disease Therapeutics
Table 46. Key Market Challenges & Risks of Parkinson's Disease Therapeutics
Table 47. Key Industry Trends of Parkinson's Disease Therapeutics
Table 48. Global Parkinson's Disease Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Parkinson's Disease Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Parkinson's Disease Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Parkinson's Disease Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Parkinson's Disease Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 54. Merck Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 55. Merck Parkinson's Disease Therapeutics Product Offered
Table 56. Merck Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Merck Main Business
Table 58. Merck Latest Developments
Table 59. Akorn Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 60. Akorn Parkinson's Disease Therapeutics Product Offered
Table 61. Akorn Main Business
Table 62. Akorn Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Akorn Latest Developments
Table 64. GSK Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 65. GSK Parkinson's Disease Therapeutics Product Offered
Table 66. GSK Main Business
Table 67. GSK Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. GSK Latest Developments
Table 69. Novartis Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 70. Novartis Parkinson's Disease Therapeutics Product Offered
Table 71. Novartis Main Business
Table 72. Novartis Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Novartis Latest Developments
Table 74. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 75. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Offered
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Boehringer Ingelheim Latest Developments
Table 79. Teva Pharmaceutical Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 80. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Offered
Table 81. Teva Pharmaceutical Main Business
Table 82. Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Teva Pharmaceutical Latest Developments
Table 84. Abbvie Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 85. Abbvie Parkinson's Disease Therapeutics Product Offered
Table 86. Abbvie Main Business
Table 87. Abbvie Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Abbvie Latest Developments
Table 89. Kyowa Hakko Kirin Pharma Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 90. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Offered
Table 91. Kyowa Hakko Kirin Pharma Main Business
Table 92. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Kyowa Hakko Kirin Pharma Latest Developments
Table 94. Astellas Pharma Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 95. Astellas Pharma Parkinson's Disease Therapeutics Product Offered
Table 96. Astellas Pharma Main Business
Table 97. Astellas Pharma Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Astellas Pharma Latest Developments
Table 99. Roche Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 100. Roche Parkinson's Disease Therapeutics Product Offered
Table 101. Roche Main Business
Table 102. Roche Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Roche Latest Developments
Table 104. H.Lundbeck Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 105. H.Lundbeck Parkinson's Disease Therapeutics Product Offered
Table 106. H.Lundbeck Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. H.Lundbeck Main Business
Table 108. H.Lundbeck Latest Developments
Table 109. Bausch Health Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 110. Bausch Health Parkinson's Disease Therapeutics Product Offered
Table 111. Bausch Health Main Business
Table 112. Bausch Health Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Bausch Health Latest Developments
Table 114. Apokyn Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 115. Apokyn Parkinson's Disease Therapeutics Product Offered
Table 116. Apokyn Main Business
Table 117. Apokyn Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Apokyn Latest Developments
Table 119. Orion Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 120. Orion Parkinson's Disease Therapeutics Product Offered
Table 121. Orion Main Business
Table 122. Orion Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Orion Latest Developments
Table 124. Stada Arzneimittel Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 125. Stada Arzneimittel Parkinson's Disease Therapeutics Product Offered
Table 126. Stada Arzneimittel Main Business
Table 127. Stada Arzneimittel Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Stada Arzneimittel Latest Developments
Table 129. US WorldMeds Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 130. US WorldMeds Parkinson's Disease Therapeutics Product Offered
Table 131. US WorldMeds Main Business
Table 132. US WorldMeds Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. US WorldMeds Latest Developments
Table 134. Desitin Arzneimittel Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 135. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Offered
Table 136. Desitin Arzneimittel Main Business
Table 137. Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Desitin Arzneimittel Latest Developments
Table 139. Endo Pharmaceuticals Details, Company Type, Parkinson's Disease Therapeutics Area Served and Its Competitors
Table 140. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Offered
Table 141. Endo Pharmaceuticals Main Business
Table 142. Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Endo Pharmaceuticals Latest Developments
List of Figures
Figure 1. Parkinson's Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson's Disease Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Parkinson's Disease Therapeutics Market Size Market Share by Type in 2021
Figure 7. Parkinson's Disease Therapeutics in Under 40 Years Old
Figure 8. Global Parkinson's Disease Therapeutics Market: Under 40 Years Old (2017-2022) & ($ Millions)
Figure 9. Parkinson's Disease Therapeutics in 40-65 Years Old
Figure 10. Global Parkinson's Disease Therapeutics Market: 40-65 Years Old (2017-2022) & ($ Millions)
Figure 11. Parkinson's Disease Therapeutics in Above 65 Years Old
Figure 12. Global Parkinson's Disease Therapeutics Market: Above 65 Years Old (2017-2022) & ($ Millions)
Figure 13. Global Parkinson's Disease Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Parkinson's Disease Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Parkinson's Disease Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Parkinson's Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Parkinson's Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Parkinson's Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Parkinson's Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Parkinson's Disease Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Parkinson's Disease Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Parkinson's Disease Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Parkinson's Disease Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Parkinson's Disease Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Parkinson's Disease Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Parkinson's Disease Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Parkinson's Disease Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Parkinson's Disease Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Parkinson's Disease Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Parkinson's Disease Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Parkinson's Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Parkinson's Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Parkinson's Disease Therapeutics Market Size 202
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
